902
Participants
Start Date
June 10, 2024
Primary Completion Date
December 25, 2024
Study Completion Date
March 5, 2025
SP (Macleods Pharmaceuticals Ltd)
Children who weigh \<10kg will receive Sulfadoxine-pyrimethamine paediatric formulation (250mg/12.5mg) dispersable tablets; children who weigh \>10kg will receive 500mg sulfadoxine plus 25mg pyrimethamine
SPAQ (Guilin Pharmaceuticals)
Children will receive 500mg sulfadoxine plus 25mg pyrimethamine as one tablet, and 153mg amodiaquine (as hydrochloride) as one tablet on Day 0, and Children will 153mg amodiaquine (as hydrochloride) as one tablet on days 1 and 2.
AS (Guilin Pharmaceuticals)
Children will receive 4 mg/kg/day for 7 days
Malantouen District Hospital Catchment Area, Magba
London School of Hygiene and Tropical Medicine
OTHER